Expression of ribozymes in gene transfer systems to modulate target RNA levels (Q45890110)

17 December 2017

review article

1 reference

title

Expression of ribozymes in gene transfer systems to modulate target RNA levels (English)

1 reference

17 December 2017

3

Wong-Staal F

1 reference

17 December 2017

author name string

Welch PJ

series ordinal

1

1 reference

17 December 2017

Barber JR

series ordinal

2

1 reference

17 December 2017

publication date

1 October 1998

1 reference

17 December 2017

Current Opinion in Biotechnology

published in

1 reference

17 December 2017

volume

9

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

486-496

1 reference

17 December 2017

Hammerhead ribozyme activity in the presence of low molecular weight cellular extract

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Facilitated reduction of beta-amyloid peptide precursor by synthetic oligonucleotides in COS-7 cells expressing a hammerhead ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Chemical engineering of RNase resistant and catalytically active hammerhead ribozymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Progress toward the structure and therapeutic use of the hairpin ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Design and preparation of a multimeric self-cleaving hammerhead ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Expression of small, therapeutic RNAs in human cell nuclei.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Adenovirus-mediated expression of ribozymes in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Multi-unit anti-BCR-ABL ribozyme therapy in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

The subcellular localization and length of hammerhead ribozymes determine efficacy in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Colocalization of antisense RNAs and ribozymes with their target mRNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Efficient expression by an alphavirus replicon of a functional ribozyme targeted to human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Evaluating and enhancing ribozyme reaction efficiency in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Ribozyme-mediated attenuation of pancreatic beta-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

HER-2/neu is rate-limiting for ovarian cancer growth. Conditional depletion of HER-2/neu by ribozyme targeting.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Intracellular application of hairpin ribozyme genes against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Ribozyme-based gene cleavage approach to chronic arthritis associated with human T cell leukemia virus type I: induction of apoptosis in synoviocytes by ablation of HTLV-I tax protein

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Efficient transfer of synthetic ribozymes into cells using hemagglutinating virus of Japan (HVJ)-cationic liposomes. Application for ribozymes that target human t-cell leukemia virus type I tax/rex mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Inhibition of FIV replication by a ribozyme that targets the Rev response element

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Inhibition of Moloney murine leukaemia virus by a retroviral vector, LNL6, carrying ribozymes targeted to the 5' non-coding sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: preclinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Adenovirus-mediated transduction of ribozymes abrogates HER-2/neu and pleiotrophin expression and inhibits tumor cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Growth arrest of Epstein-Barr virus immortalized B lymphocytes by adenovirus-delivered ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Stable integration of human immunodeficiency virus-based retroviral vectors into the chromosomes of nondividing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Ex vivo effects associated with the expression of a bcr-abl-specific ribozyme in a CML cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Specific bcr-abl-directed antisense nucleic acids and ribozymes: a tool for the treatment of chronic myelogenous leukemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Abrogation of lung metastasis of human fibrosarcoma cells by ribozyme-mediated suppression of integrin alpha6 subunit expression

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Translating genomics information into therapeutics: a key role for oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Ribozyme-mediated suppression of the G protein gamma7 subunit suggests a role in hormone regulation of adenylylcyclase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Selection of the best target site for ribozyme-mediated cleavage within a fusion gene for adenovirus E1A-associated 300 kDa protein (p300) and luciferase.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Ribozyme trans-splicing and RNA tagging: following the messenger

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Use of engineered ribozymes to catalyze chimeric gene assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

RNA-catalysed carbon–carbon bond formation

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Peptide bond formation by in vitro selected ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

The New World of ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

A minimised hammerhead ribozyme with activity against interleukin-2 in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

In vitro selection of a purine nucleotide-specific hammerheadlike ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Isolation of hammerhead ribozymes with altered core sequences by in vitro selection

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

1 reference

7 January 2021

Inhibition of HIV-1 replication by an anti-tat hammerhead ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Efficient long-term coexpression of a hammerhead ribozyme targeted to the U5 region of HIV-1 LTR by linkage to the multidrug-resistance gene

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Inhibition of human immunodeficiency virus type 1 replication by nuclear chimeric anti-HIV ribozymes in a human T lymphoblastoid cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Nucleic acid-based antiviral and gene therapy of chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Use of a nonviral vector to express a chimeric tRNA-ribozyme against lymphocytic choriomeningitis virus: cytoplasmic accumulation of a catalytically competent transcript but minimal antiviral effect

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Intracellular immunization against SIVmac utilizing a hairpin ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Modulation of c-fms proto-oncogene in an ovarian carcinoma cell line by a hammerhead ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Specific hammerhead ribozyme-mediated cleavage of mutant N-ras mRNA in vitro and ex vivo. Oligoribonucleotides as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Inhibition of tumor growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Delivery of a hammerhead ribozyme specifically down-regulates the production of fibrillin-1 by cultured dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Inhibition of fibrillin 1 expression using U1 snRNA as a vehicle for the presentation of antisense targeting sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Ribozyme modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by peritoneal cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Reduced beta 2-microglobulin mRNA levels in transgenic mice expressing a designed hammerhead ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Efficient and specific ribozyme-mediated reduction of bovine alpha-lactalbumin expression in double transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

Regulation of CAT protein by ribozyme and antisense mRNA in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2898%2980034-7

7 January 2021

10.1016/S0958-1669(98)80034-7

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

9821277

1 reference

17 December 2017